Spinal Muscular Atrophy Medicine Market Report

Global and China Spinal Muscular Atrophy Medicine Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 25, 2022
  • PAGES：170
  • REPORT CODE：GMM1494489
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Spinal Muscular Atrophy Medicine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bioblast Pharma Ltd

    • AveXis, Inc

    • Vybion, Inc

    • Sarepta Therapeutics, Inc

    • Astellas Pharma Inc

    • WAVE Life Sciences Ltd

    • F Hoffmann-La Roche Ltd

    • Neurotune AG

    • Longevity Biotech, Inc

    • Genzyme Corporation

    • Genethon

    • Ionis Pharmaceuticals, Inc

    • Voyager Therapeutics, Inc

    • Neurodyn Inc

    • GMP-Orphan SAS

    • Cytokinetics, Inc 24

    • Novartis AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • LMI-070

    • ND-602

    • NT-1654

    • Nusinersen

    • NXD-30001

    • Others

    Application:

    • Hospital

    • Clinic

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Spinal Muscular Atrophy Medicine Industry Overview

      • 1.1.1 Spinal Muscular Atrophy Medicine Market Scope and Market Segments

      • 1.1.2 Spinal Muscular Atrophy Medicine Industry Characteristics

      • 1.1.3 Global and China Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Spinal Muscular Atrophy Medicine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 LMI-070

      • 1.2.2 ND-602

      • 1.2.3 NT-1654

      • 1.2.4 Nusinersen

      • 1.2.5 NXD-30001

      • 1.2.6 Others

    • 1.3 Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Spinal Muscular Atrophy Medicine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Spinal Muscular Atrophy Medicine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Spinal Muscular Atrophy Medicine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Spinal Muscular Atrophy Medicine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Spinal Muscular Atrophy Medicine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Spinal Muscular Atrophy Medicine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Spinal Muscular Atrophy Medicine Industry PEST Analysis

    • 2.3 Spinal Muscular Atrophy Medicine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Spinal Muscular Atrophy Medicine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Spinal Muscular Atrophy Medicine Industry

    Chapter 3 Global and China Spinal Muscular Atrophy Medicine Market, by Manufacturer

    • 3.1 Global and China Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Spinal Muscular Atrophy Medicine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Spinal Muscular Atrophy Medicine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Spinal Muscular Atrophy Medicine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Spinal Muscular Atrophy Medicine Market Top 3 Players

    Chapter 4 Global and China Spinal Muscular Atrophy Medicine Market, by Type (2017-2028)

    • 4.1 Spinal Muscular Atrophy Medicine Market Trend, by Type

    • 4.2 Global Spinal Muscular Atrophy Medicine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Spinal Muscular Atrophy Medicine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Spinal Muscular Atrophy Medicine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Spinal Muscular Atrophy Medicine Price Trend, by Type (2017-2028)

    • 4.3 China Spinal Muscular Atrophy Medicine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Spinal Muscular Atrophy Medicine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Spinal Muscular Atrophy Medicine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Spinal Muscular Atrophy Medicine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Spinal Muscular Atrophy Medicine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Spinal Muscular Atrophy Medicine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Spinal Muscular Atrophy Medicine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Spinal Muscular Atrophy Medicine Market Analysis

    • 7.1 North America Spinal Muscular Atrophy Medicine Market, by Type

    • 7.2 North America Spinal Muscular Atrophy Medicine Market, by Application

    • 7.3 North America Spinal Muscular Atrophy Medicine Market Analysis and Forecast, by Country

      • 7.3.1 United States Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Spinal Muscular Atrophy Medicine Market Analysis

    • 8.1 Europe Spinal Muscular Atrophy Medicine Market, by Type

    • 8.2 Europe Spinal Muscular Atrophy Medicine Market, by Application

    • 8.3 Europe Spinal Muscular Atrophy Medicine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Spinal Muscular Atrophy Medicine Market Analysis

    • 9.1 APAC Spinal Muscular Atrophy Medicine Market, by Type

    • 9.2 APAC Spinal Muscular Atrophy Medicine Market, by Application

    • 9.3 APAC Spinal Muscular Atrophy Medicine Market Analysis and Forecast, by Country

      • 9.3.1 China Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Market Analysis

    • 10.1 Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Market, by Type

    • 10.2 Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Market, by Application

    • 10.3 Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Spinal Muscular Atrophy Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Spinal Muscular Atrophy Medicine Company Profiles

      • 11.1 Bioblast Pharma Ltd

        • 11.1.1 Bioblast Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bioblast Pharma Ltd Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.1.3 Bioblast Pharma Ltd Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 AveXis, Inc

        • 11.2.1 AveXis, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 AveXis, Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.2.3 AveXis, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Vybion, Inc

        • 11.3.1 Vybion, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Vybion, Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.3.3 Vybion, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Sarepta Therapeutics, Inc

        • 11.4.1 Sarepta Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Sarepta Therapeutics, Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.4.3 Sarepta Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Astellas Pharma Inc

        • 11.5.1 Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Astellas Pharma Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.5.3 Astellas Pharma Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 WAVE Life Sciences Ltd

        • 11.6.1 WAVE Life Sciences Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 WAVE Life Sciences Ltd Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.6.3 WAVE Life Sciences Ltd Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 F Hoffmann-La Roche Ltd

        • 11.7.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 F Hoffmann-La Roche Ltd Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.7.3 F Hoffmann-La Roche Ltd Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Neurotune AG

        • 11.8.1 Neurotune AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Neurotune AG Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.8.3 Neurotune AG Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Longevity Biotech, Inc

        • 11.9.1 Longevity Biotech, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.9.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Genzyme Corporation

        • 11.10.1 Genzyme Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Genzyme Corporation Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.10.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Genethon

        • 11.11.1 Genethon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Genethon Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.11.3 Genethon Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Ionis Pharmaceuticals, Inc

        • 11.12.1 Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Ionis Pharmaceuticals, Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.12.3 Ionis Pharmaceuticals, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Voyager Therapeutics, Inc

        • 11.13.1 Voyager Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Voyager Therapeutics, Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.13.3 Voyager Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Neurodyn Inc

        • 11.14.1 Neurodyn Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Neurodyn Inc Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.14.3 Neurodyn Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 GMP-Orphan SAS

        • 11.15.1 GMP-Orphan SAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.15.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Cytokinetics, Inc 24

        • 11.16.1 Cytokinetics, Inc 24 Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Cytokinetics, Inc 24 Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.16.3 Cytokinetics, Inc 24 Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Novartis AG

        • 11.17.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Novartis AG Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification

        • 11.17.3 Novartis AG Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Spinal Muscular Atrophy Medicine Industry Investment Prospect and Risk Assessment

    • 12.1 Spinal Muscular Atrophy Medicine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Spinal Muscular Atrophy Medicine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Production Value and Growth Rate (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Production Value and Growth Rate (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of LMI-070 (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of ND-602 (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NT-1654 (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Nusinersen (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of NXD-30001 (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Spinal Muscular Atrophy Medicine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Spinal Muscular Atrophy Medicine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Spinal Muscular Atrophy Medicine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Spinal Muscular Atrophy Medicine Market Share, by Manufacturer in 2021

    • Figure Global and China Spinal Muscular Atrophy Medicine Market Share, by Manufacturer in 2022

    • Table Global Spinal Muscular Atrophy Medicine Sales Volume, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Sales Value, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Sales Value Share, by Type (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Price Trend, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Volume, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Value, by Type (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Value Share, by Type (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Price Trend, by Type (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Sales Volume, by Application (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Sales Value, by Application (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Sales Value Share, by Application (2017-2028)

    • Figure Global Spinal Muscular Atrophy Medicine Sales Value Share, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Volume, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Value, by Application (2017-2028)

    • Table China Spinal Muscular Atrophy Medicine Sales Value Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Sales Value Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Production, Import, Consumption and Export (2017-2022)

    • Table North America Spinal Muscular Atrophy Medicine Sales Volume, by Type (2017-2028)

    • Table North America Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Figure North America Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Table North America Spinal Muscular Atrophy Medicine Sales Volume, by Application (2017-2028)

    • Table North America Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure North America Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure United States Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Table Europe Spinal Muscular Atrophy Medicine Sales Volume, by Type (2017-2028)

    • Table Europe Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Table Europe Spinal Muscular Atrophy Medicine Sales Volume, by Application (2017-2028)

    • Table Europe Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure UK Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure France Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure France Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Table APAC Spinal Muscular Atrophy Medicine Sales Volume, by Type (2017-2028)

    • Table APAC Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Table APAC Spinal Muscular Atrophy Medicine Sales Volume, by Application (2017-2028)

    • Table APAC Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure China Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure India Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure India Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Spinal Muscular Atrophy Medicine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Spinal Muscular Atrophy Medicine Sales Value and Growth Rate (2017-2028)

    • Table Bioblast Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bioblast Pharma Ltd Product Profiles, Application and Specification

    • Table Bioblast Pharma Ltd Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AveXis, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AveXis, Inc Product Profiles, Application and Specification

    • Table AveXis, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Vybion, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Vybion, Inc Product Profiles, Application and Specification

    • Table Vybion, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sarepta Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sarepta Therapeutics, Inc Product Profiles, Application and Specification

    • Table Sarepta Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Inc Product Profiles, Application and Specification

    • Table Astellas Pharma Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table WAVE Life Sciences Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table WAVE Life Sciences Ltd Product Profiles, Application and Specification

    • Table WAVE Life Sciences Ltd Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Neurotune AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Neurotune AG Product Profiles, Application and Specification

    • Table Neurotune AG Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Longevity Biotech, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Longevity Biotech, Inc Product Profiles, Application and Specification

    • Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genzyme Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genzyme Corporation Product Profiles, Application and Specification

    • Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genethon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genethon Product Profiles, Application and Specification

    • Table Genethon Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ionis Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Ionis Pharmaceuticals, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Voyager Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Voyager Therapeutics, Inc Product Profiles, Application and Specification

    • Table Voyager Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Neurodyn Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Neurodyn Inc Product Profiles, Application and Specification

    • Table Neurodyn Inc Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GMP-Orphan SAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GMP-Orphan SAS Product Profiles, Application and Specification

    • Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cytokinetics, Inc 24 Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cytokinetics, Inc 24 Product Profiles, Application and Specification

    • Table Cytokinetics, Inc 24 Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Spinal Muscular Atrophy Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US